Report Detail
Global (United States, European Union and China) Generic Sterile Injectable Market Research Report 2019-2025
- RnM3650262 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.
The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
In 2019, the market size of Generic Sterile Injectable is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Generic Sterile Injectable.
This report studies the global market size of Generic Sterile Injectable, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Generic Sterile Injectable sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy’s
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab
Market Segment by Product Type
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Others
Market Segment by Application
Hospitals
Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Generic Sterile Injectable status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Generic Sterile Injectable manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Generic Sterile Injectable are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Generic Sterile Injectable Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Monoclonal Antibodies
- 1.3.3 Cytokines
- 1.3.4 Insulin
- 1.3.5 Peptide Hormones
- 1.3.6 Vaccines
- 1.3.7 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Generic Sterile Injectable Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Generic Sterile Injectable Market Size
- 2.1.1 Global Generic Sterile Injectable Revenue 2014-2025
- 2.1.2 Global Generic Sterile Injectable Sales 2014-2025
- 2.2 Generic Sterile Injectable Growth Rate by Regions
- 2.2.1 Global Generic Sterile Injectable Sales by Regions 2014-2019
- 2.2.2 Global Generic Sterile Injectable Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Generic Sterile Injectable Sales by Manufacturers
- 3.1.1 Generic Sterile Injectable Sales by Manufacturers 2014-2019
- 3.1.2 Generic Sterile Injectable Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Generic Sterile Injectable Revenue by Manufacturers (2014-2019)
- 3.2.2 Generic Sterile Injectable Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Generic Sterile Injectable Market Concentration Ratio (CR5 and HHI)
- 3.3 Generic Sterile Injectable Price by Manufacturers
- 3.4 Key Manufacturers Generic Sterile Injectable Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Generic Sterile Injectable Market
- 3.6 Key Manufacturers Generic Sterile Injectable Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Monoclonal Antibodies Sales and Revenue (2014-2019)
- 4.1.2 Cytokines Sales and Revenue (2014-2019)
- 4.1.3 Insulin Sales and Revenue (2014-2019)
- 4.1.4 Peptide Hormones Sales and Revenue (2014-2019)
- 4.1.5 Vaccines Sales and Revenue (2014-2019)
- 4.1.6 Others Sales and Revenue (2014-2019)
- 4.2 Global Generic Sterile Injectable Sales Market Share by Type
- 4.3 Global Generic Sterile Injectable Revenue Market Share by Type
- 4.4 Generic Sterile Injectable Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Generic Sterile Injectable Sales by Application
6 United States
- 6.1 United States Generic Sterile Injectable Breakdown Data by Company
- 6.2 United States Generic Sterile Injectable Breakdown Data by Type
- 6.3 United States Generic Sterile Injectable Breakdown Data by Application
7 European Union
- 7.1 European Union Generic Sterile Injectable Breakdown Data by Company
- 7.2 European Union Generic Sterile Injectable Breakdown Data by Type
- 7.3 European Union Generic Sterile Injectable Breakdown Data by Application
8 China
- 8.1 China Generic Sterile Injectable Breakdown Data by Company
- 8.2 China Generic Sterile Injectable Breakdown Data by Type
- 8.3 China Generic Sterile Injectable Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Generic Sterile Injectable Breakdown Data by Company
- 9.2 Rest of World Generic Sterile Injectable Breakdown Data by Type
- 9.3 Rest of World Generic Sterile Injectable Breakdown Data by Application
- 9.4 Rest of World Generic Sterile Injectable Breakdown Data by Countries
- 9.4.1 Rest of World Generic Sterile Injectable Sales by Countries
- 9.4.2 Rest of World Generic Sterile Injectable Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 3M
- 10.1.1 3M Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.1.4 Generic Sterile Injectable Product Introduction
- 10.1.5 3M Recent Development
- 10.2 Baxter Inc
- 10.2.1 Baxter Inc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.2.4 Generic Sterile Injectable Product Introduction
- 10.2.5 Baxter Inc Recent Development
- 10.3 Fresenius Kabi
- 10.3.1 Fresenius Kabi Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.3.4 Generic Sterile Injectable Product Introduction
- 10.3.5 Fresenius Kabi Recent Development
- 10.4 Pfizer/Hospira
- 10.4.1 Pfizer/Hospira Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.4.4 Generic Sterile Injectable Product Introduction
- 10.4.5 Pfizer/Hospira Recent Development
- 10.5 Novartis/Sandoz
- 10.5.1 Novartis/Sandoz Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.5.4 Generic Sterile Injectable Product Introduction
- 10.5.5 Novartis/Sandoz Recent Development
- 10.6 Teva
- 10.6.1 Teva Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.6.4 Generic Sterile Injectable Product Introduction
- 10.6.5 Teva Recent Development
- 10.7 Hikma
- 10.7.1 Hikma Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.7.4 Generic Sterile Injectable Product Introduction
- 10.7.5 Hikma Recent Development
- 10.8 Sun Pharma
- 10.8.1 Sun Pharma Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.8.4 Generic Sterile Injectable Product Introduction
- 10.8.5 Sun Pharma Recent Development
- 10.9 Dr. Reddy’s
- 10.9.1 Dr. Reddy’s Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.9.4 Generic Sterile Injectable Product Introduction
- 10.9.5 Dr. Reddy’s Recent Development
- 10.10 Mylan
- 10.10.1 Mylan Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Generic Sterile Injectable
- 10.10.4 Generic Sterile Injectable Product Introduction
- 10.10.5 Mylan Recent Development
- 10.11 AstraZeneca Plc
- 10.12 Merck & Co., Inc
- 10.13 Hellberg Safety Ab
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Generic Sterile Injectable Sales Channels
- 11.2.2 Generic Sterile Injectable Distributors
- 11.3 Generic Sterile Injectable Customers
12 Market Forecast
- 12.1 Global Generic Sterile Injectable Sales and Revenue Forecast 2019-2025
- 12.2 Global Generic Sterile Injectable Sales Forecast by Type
- 12.3 Global Generic Sterile Injectable Sales Forecast by Application
- 12.4 Generic Sterile Injectable Forecast by Regions
- 12.4.1 Global Generic Sterile Injectable Sales Forecast by Regions 2019-2025
- 12.4.2 Global Generic Sterile Injectable Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Generic Sterile Injectable. Industry analysis & Market Report on Generic Sterile Injectable is a syndicated market report, published as Global (United States, European Union and China) Generic Sterile Injectable Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Generic Sterile Injectable market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
